DSX, CRWE, AONE, ATHX, GALE, - CRWESelect.com Stock News! Diana Shipping, Crown Equity Holdings, A123 Systems, Athersys, Galena Biopharma (Video Included Inside)

FOR IMMEDIATE RELEASE
Las Vegas, Nevada, United States of America (Free-Press-Release.com) November 13, 2011 -- To view video, and read the full article visit URL http://crweselect.com/27332/stock-alerts/dsx-crwe-aone-athx-gale-crweselectcom-stock-news-diana-shipping-crown-equity-holdings-a123-systems-athersys-galena-biopharma-video-included-inside/

Diana Shipping Inc. (NYSE:DSX)

DSX previously announced that it has entered into a time charter contract with Hyundai Merchant Marine Co. Ltd, Seoul, South Korea, for one of its Panamax dry bulk carriers, the m/v Erato, at a gross rate of US$12,200 per day, minus a 5% commission paid to third parties for a minimum thirteen (13) to about sixteen (16) month period. The charter is expected to commence early December 2011. This employment is expected to generate approximately US$4.76 million of gross revenues for the minimum scheduled period of the charter.

DSX financial results for its third quarter fiscal 2011 are scheduled to be released before the opening of the U.S. financial markets on
Wednesday, November 23, 2011.

DSX is a leading global provider of shipping transportation services through the ownership and operation of dry bulk vessels. DSX vessels are employed primarily on medium to long-term time charters and transport a range of dry bulk cargoes, including such commodities as iron ore, coal, grain and other materials along worldwide shipping routes.

For more information about DSX please visit http://www.dianashippinginc.com

****

Crown Equity Holdings Inc. (CRWE.OB)

CRWE previously has entered into a joint venture to deploy VoIP (Voice over Internet Protocol) technology delivering voice, video and data services to residential and commercial customers. The joint venture company is Crown Tele Services Inc. which was a wholly-owned subsidiary of Crown Equity Holdings Inc. CRWE will own the remaining fifty percent (50%) interest in the joint venture.

According to IBISWorld Industry Reports, Digital voice will be the fastest growing U.S. industry in the next five years. Voice over Internet Protocol leads the list of the ten most dynamic industries with revenue in 2010 of nearly $12.5 billion dollars, growth 2000 - 2010 of 194% and forecast growth 2010 - 2016 of 17.6%

According to ABI Research, the latest global business VoIP services forecasts show that the value of the overall market, which includes VoIP integrated access, SIP trunking, hosted IP-PBX/IP Centrex and managed IP-PBX services, is set to double over the next five years, to exceed $20 billion by 2015.

CRWE, together with its digital network of Websites, offers advertising branding and marketing services as a worldwide online multi-media publisher. CRWE focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. Its advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness.

CRWE has extended its CRWENEWSWIRE global platform web presence and is now publishing online news and information to the following countries: Argentina, Australia, Brazil, China, France, Germany, India, Ireland, Italy, Japan, Malaysia, Mexico, New Zealand, Russia, Singapore, South Africa, South Korea, Spain, Taiwan, United Arab Emirates and the United Kingdom, using their specific country code domain and native language.

For more information about CRWE please visit http://www.crownequityholdings.com

****

A123 Systems, Inc. (Nasdaq:AONE) has previously revised revenue guidance range for the full year 2011 due to unanticipated developments that will impact fourth quarter revenue.

A123 now projects that 2011 revenue will be in the range of $165 million to $180 million, which would represent 70 percent to 85 percent revenue growth from 2010. A123's previous 2011 revenue guidance range was $210 million to $225 million. The reduction in full-year revenue guidance will be reflected principally in the fourth quarter.

A123 Systems, Inc. is a leading developer and manufacturer of advanced lithium-ion batteries and energy storage systems for transportation, electric grid and commercial applications. The company's proprietary Nanophosphate(R) technology is built on novel nanoscale materials initially developed at the Massachusetts Institute of Technology and is designed to deliver high power and energy density, increased safety and extended life. A123 leverages breakthrough technology, high-quality manufacturing and expert systems integration capabilities to deliver innovative solutions that enable customers to bring next-generation products to market.

****

Athersys, Inc. (Nasdaq:ATHX) previously reported the online publication in Circulation Research of results from a Phase I clinical study that found that the delivery of MultiStem® was safe and well tolerated in patients who had recently suffered an acute myocardial infarction (AMI).

The data also suggest improved cardiovascular performance, particularly among patients with severely compromised heart function.

Athersys is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing MultiStem(R), a patented, adult-derived "off-the-shelf" stem cell product platform for multiple disease indications, including damage caused by myocardial infarction, bone marrow transplantation and oncology treatment support, ischemic stroke, and inflammatory bowel disease. The Company is also developing a portfolio of other therapeutic programs, including orally active pharmaceutical product candidates for the treatment of metabolic and central nervous system disorders, utilizing proprietary technologies, including Random Activation of Gene Expression (RAGE(R)). Athersys has forged several key strategic alliances and collaborations with leading pharmaceutical and biotechnology companies, as well as world-renowned research institutions in the United States and Europe to further develop its platform and products.

****

Galena Biopharma, Inc. (Nasdaq:GALE) previously reported that positive data from Phase 2 clinical trials of NeuVax(tm) was presented at the 26th Annual Meeting of the Society for the Immunotherapy of Cancer.

Galena Biopharma, Inc. is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care.

To read the full article visit URL http://crweselect.com/27332/stock-alerts/dsx-crwe-aone-athx-gale-crweselectcom-stock-news-diana-shipping-crown-equity-holdings-a123-systems-athersys-galena-biopharma-video-included-inside/

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer(http://crweselect.com/disclaimer/) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

CRWEcrweselect1113
DSXcrweselect1113

A123 Systems     aone     Athersys     ATHX     CRWE.OB     Diana Shipping     DSX     Galena Biopharma